is this sensible:
- the product sales were $200k in the Q, and say that is only Dec sales kick off; can we say the baseline right now for the FebriDx and ViraDx is $200k a month - or say $600k a q
- the services were $1.5 mill for the q and they say that is expected 'to continue';
- add onto that the new Hologic contract 4.7 mill over 18 months - or $800k a q
- so product 600k/q and services 1.5m/q and Hologic contract 800k/q yields 2.9mill/q revenue USD, let us go let us say the margin is 30 to 50%; so 'profit' on operations (not taking in admin and all that) is say $1.3 USD mill a q
...so a company that has operational cash flow 'operations profit' $5.2 mill USD or $8 mill AUD a year... what is that worth?
Of course that depends on the monies allocated to non-operations... that is admin, growth, etc.; they said they are 'spending' .9 mill month USD on this, say $1.3 mill AUD, so cash flow, overall Lumos at its current 'output' is still losing substantial money; $700k AUD 'ops profit' per month vs 1.3 mill AUD overheads = losing $600k per month AUD
- now of course selling IP for $15 mill AUD one off sugar hit 'covers overheads' for 25 months
The goal of course, is to become ongoing profitable = ops profit more than covers all other costs; so the current revenue needs to double - that can come from a mix of services and product sales; so now the NEXT Q is vital to see how much product sales have grown from the current baseline; this fin year, will clearly show a profit (with that $15 mill IP revenue); not much of a profit, but a paper profit; what will the next fin year do (if we double revenue then a profit appears again - but not by much)
So... I can see small profit THIS year and small profit NEXT year; it would only be the fin year 2025-26 that can be the exploding company value (if revenue continues to grow)
I get back to 'how to value' a company with so many unknowns; the short answer is: one cannot; maybe 7.7 cents is fair value, maybe 10 cents, maybe 50 cents, maybe the IPO of $1.20; ahh the old day traders, the TA traders, the news traders will have fun with so much fundamental uncertainty
- Forums
- ASX - By Stock
- LDX
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
LDX
lumos diagnostics holdings limited
Add to My Watchlist
0.00%
!
2.9¢

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-27
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
2.9¢ |
Change
0.000(0.00%) |
Mkt cap ! $21.70M |
Open | High | Low | Value | Volume |
2.9¢ | 2.9¢ | 2.9¢ | $1.912K | 65.93K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 571666 | 2.8¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
3.0¢ | 150000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 506666 | 0.028 |
3 | 318288 | 0.027 |
2 | 443000 | 0.026 |
6 | 601153 | 0.025 |
1 | 1238229 | 0.024 |
Price($) | Vol. | No. |
---|---|---|
0.030 | 150000 | 1 |
0.031 | 250309 | 3 |
0.032 | 51725 | 1 |
0.033 | 190000 | 1 |
0.034 | 189253 | 1 |
Last trade - 10.42am 20/06/2025 (20 minute delay) ? |
Featured News
LDX (ASX) Chart |